Effect of capsule treatment on visual acuity and quality after phacoemulsification lens implantation in myopic patients with cataract

doi:10.12998/wjcc.v12.i19.3882

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 19

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (55)

All Articles published online

The chart showing PDF series, HTML series, Tables (1-4) series.

Item

Count

PDF

HTML

Tables (1-4)

Sum=34

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=19

Jul 6, 2024 (publication date) through Jun 30, 2024

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Cases

ISSN

2307-8960

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Randomized Clinical Trial

World J Clin Cases. Jul 6, 2024; 12(19): 3882-3889
Published online Jul 6, 2024. doi: 10.12998/wjcc.v12.i19.3882

Effect of capsule treatment on visual acuity and quality after phacoemulsification lens implantation in myopic patients with cataract

Wei Liu, Qi Liu, Fang Zhou, Bo Feng, Wan-Ling Wu

Wei Liu, Qi Liu, Fang Zhou, Bo Feng, Wan-Ling Wu, Glaucoma Cataract Department, Ganzhou Aier Eye Hospital, Ganzhou 341099, Jiangxi Province, China

Author contributions: Liu W, Feng B and Wu WL designed this research; Liu W and Liu Q performed this research; Liu W and Zhou F analyzed the data; Liu W, Feng B and Wu WL wrote the manuscript.

Institutional review board statement: This study was approved by the institutional review board of Ganzhou Aier Ophthalmology Hospital.

Informed consent statement: The informed consent has been obtained form each participant.

Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.

Data sharing statement: The data are available from the corresponding author.

CONSORT 2010 statement: The authors have read the CONSORT 2010 statement, and the manuscript was prepared and revised according to the CONSORT 2010 statement.

Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Bo Feng, BSc, Attending Doctor, Glaucoma Cataract Department, Ganzhou Aier Eye Hospital, No. 81 Limukeng, Zhanggong District, Ganzhou 341099, Jiangxi Province, China. fengbo9778@163.com

Received: April 10, 2024
Revised: May 10, 2024
Accepted: May 20, 2024
Published online: July 6, 2024
Processing time: 79 Days and 22 Hours

Core Tip

Core Tip: This study attempted to observe the application value of capsular membrane treatment in myopia with cataract phacoemulsification crystal implantation. The observation indicators included patients' visual acuity and visual quality, and the preliminary study results found that it had certain clinical application value.